Shares of Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $26.30, but opened at $25.65. Ascentage Pharma Group International shares last traded at $25.03, with a volume of 1,265 shares.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. started coverage on Ascentage Pharma Group International in a report on Thursday, March 27th. They issued an “overweight” rating on the stock.
Read Our Latest Report on AAPG
Ascentage Pharma Group International Trading Down 4.3 %
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
See Also
- Five stocks we like better than Ascentage Pharma Group International
- What is the Hang Seng index?
- Best Defense Stocks in 2025… So Far
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
